Global Fintech Entrepreneur

Dave Van Niekerk

Global Fintech Entrepreneur

Dave Van Niekerk

About Dave

Dave Van Niekerk brings over 20 years of expertise in banking, microfinance, and executive leadership. He is widely recognized across Pan-African markets for founding MyBucks, a fintech company that operated in 13 countries across Africa, Europe, and Australia. As the founder and former CEO of Blue Financial Services, Dave led the company’s expansion into 14 countries, achieving a turnover of R700 million and a loan book of approximately $400 million by 2009.

Today, as CEO of Numeral XII, Dave is channeling his entrepreneurial vision into the biotech sector, with a focus on health, longevity, and regenerative science. Described by Business Day as “SA’s own Branson,” his extensive experience in strategic growth, change management, and operational oversight positions him at the forefront of innovation in both finance and the future of health.

About Dave

Global Fintech Entrepreneur

Dave began his career in microfinance in 1997 with Unity Financial Services, where he later became a shareholder and Operational Director. After Unity’s shareholding was sold to Sanlam, Theta, and Boland Bank, it was fully acquired by Theta Investments, which already held controlling stakes in microfinance companies King and Altfin. These entities were merged under the African Bank brand, and Theta rebranded as African Bank Investments Limited.

Dave held senior management roles at African Bank until 2001, when he founded Blue Financial Services, serving as CEO until 2009. Since 2010, he has leveraged his extensive experience to consult for various financial firms, including Johannesburg Stock Exchange-listed companies, helping them raise capital, develop new revenue streams, and foster strategic business growth.

Media

Turning Health into Wealth: How Dave Van Niekerk is Betting on Africa’s Next Boom.

Africa’s next leap won’t be financial it will be biological. We’ve banked the unbanked. Now, it’s time to unlock access to health, longevity, and wellness. I’m betting that biotech, not just fintech, will power the continent’s next economic boom.

DVN Podcast

Unfiltered thoughts on business, biotech, and beyond. Welcome to the blog a space for fresh thinking, bold questions, and behind the scenes perspectives. From lessons learned on the ground to thoughts on where the world is heading, Dave shares unfiltered insights on business, biotech, and building with purpose.

FAQ’s

Setting the record straight with facts and clarity.

Here, we address the key questions raised by the media and public, providing clear, transparent responses and sharing relevant publications. Our goal is to foster understanding through openness and facts.

Numeral XII is a growth-focused investment group with a core focus on biotechnology, advancing human health and longevity through pioneering businesses in stem cell therapy, genetic research, and regenerative medicine. While biotech leads our current strategy, we build on a strong foundation in FinTech and inclusive finance, continuing to drive access to capital and scalable digital solutions.

Our portfolio spans biotech, FinTech, and agro-processing, with integrated support across legal, finance, tech, HR, and marketing — helping companies scale smarter and innovate faster. Operating across Africa, Dubai, and emerging markets, Numeral XII partners with bold founders to deliver real impact and global growth.

Visit Numeral XII